Hugo Cejas Selected Research

Immunotherapy

1/2014

Abrogation of TNFα production during cancer immunotherapy is crucial for suppressing side effects due to the systemic expression of IL-12.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hugo Cejas Research Topics

Disease

3	Infections 05/2010 - 12/2004
2	Inflammation (Inflammations) 01/2017 - 12/2015
2	Colitis 01/2017 - 12/2015
2	Neoplasms (Cancer) 01/2014 - 01/2006
2	Anorexia 09/2010 - 01/2010
1	Crohn Disease (Crohn's Disease) 12/2015
1	Ulcerative Colitis 12/2015
1	Neoplasm Metastasis (Metastasis) 01/2014
1	Body Weight (Weight, Body) 09/2010
1	Chagas Disease (American Trypanosomiasis) 05/2010
1	Parasitemia 05/2010
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 05/2010
1	Weight Loss (Weight Reduction) 01/2010
1	Smooth Muscle Tumor 01/2006
1	Carcinoma (Carcinomatosis) 01/2002
1	Adenocarcinoma 01/2002
1	Hyperplasia 01/2002

Drug/Important Bio-Agent (IBA)

2	Interleukin-12 (IL 12)IBA 01/2017 - 01/2014
2	Peroxidase (Myeloperoxidase)IBA 01/2017 - 12/2015
2	Biological ProductsIBA 12/2015 - 01/2006
1	Phenobarbital (Luminal)FDA Link 01/2017
1	Dextrans (Dextran)FDA Link 01/2017
1	Complementary DNA (cDNA)IBA 01/2017
1	SodiumIBA 01/2017
1	Dextran SulfateIBA 12/2015
1	Annexin A1IBA 12/2015
1	Type I Tumor Necrosis Factor ReceptorsIBA 12/2015
1	CytokinesIBA 01/2014
1	GlucocorticoidsIBA 09/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2010
1	Immunoglobulin G (IgG)IBA 05/2010
1	AntibodiesIBA 05/2010
1	LeptinIBA 01/2010
1	GlycogenIBA 01/2010
1	ArginaseIBA 12/2004
1	Coloring Agents (Dyes)IBA 12/2004
1	LipidsIBA 12/2004
1	Alanine Transaminase (SGPT)IBA 12/2004
1	TransferasesIBA 12/2004
1	SilverIBA 01/2002

Therapy/Procedure

2	Therapeutics 12/2015 - 01/2002
1	Immunotherapy 01/2014